Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers
pharmaceutical investing Biogen Enters Exclusive Option Agreement to Acquire TMS’ Phase 2 Asset for Acute Stroke
E-Power Resources Inc. Announces Closing of Oversubscribed Hard Dollar and Flow-through Private Placements